Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 8241–8260 of 17,773 recalls
Westminster Pharmaceuticals Llc
CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.
Sciegen Pharmaceuticals Inc
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.